Document is current
Any future updates will be listed below
-
Authors
Naitoh, Itaru
Isayama, Hiroyuki https://orcid.org/0000-0002-3308-9326
Akamatsu, Nobuhisa
Mizuno, Suguru
Fujisawa, Toshio
Nakamoto, Nobuhiro
Nakai, Yousuke
Umetsu, Shuichiro
Suzuki, Mitsuyoshi
Yagi, Shintaro
Haga, Hironori
Notohara, Kenji
Sano, Katsuhiro
Tazuma, Susumu
Nakazawa, Takahiro
Tanaka, Atsushi
-
Funding
Funding for this research was provided by:
Japan Intractable Diseases Research Foundation (JPMH23FC1015)
- License Information
-
More Information
Article History
Received: 27 December 2024
Accepted: 18 May 2025
First Online: 12 June 2025
Declarations
:
: AT is an advisor of Kaken Pharmaceutical Co Ltd., Kowa Company and GSK. AT received honorariums from Gilead Sciences. No other authors have a conflict of interest to declare.
